Current Projects

Utilizing Genomind Genetic Testing to Identify Pharmacodynamic Correlations Between Genetic Markers and the Efficacy and Tolerability of Common Antidepressant Treatments for Patients with Major Depression

STUDY AIM

Create a patient registry containing key data elements of patients who have participated in Genomind Genecept 2.0 Assay genetic testing to identify pharmacodynamic correlations between genetic markers and the efficacy and tolerability of common antidepressant treatments. Determine a probability of response and tolerability to antidepressants for patients diagnosed with major depression, based upon pharmacodynamic epistatic genetic markers obtained by utilizing the Genomind Genecept 2.0 Assay.